SlideShare a Scribd company logo
CONTROVERSIES IN
AESTHETIC GYNECOLOGY
Prof. Aboubakr Elnashar
Benha university Hospital, Egypt
ABOUBAKR ELNASHAR
ABOUBAKR ELNASHAR
CONTENTS
 INTRODUCTION
1. DEFINITION
2. STATISTICS
3. CAUSES OF INCREASED DEMAND FOR FGCS
4. INDICATIONS
5. PROCEDURES
6. OUTCOMES
 CONTROVERSY
1. OPPONENTS
2. PROPONENTS
3. ETHICAL GUIDELINES
 Aesthetic Gynecology: Aes G
Alteration of anatomy
vaginal or labial: for
Aesthetic reasons (artistic& visual) or
Treatment of normal changes that occur throughout
the life span.
Cosmetic procedures
Non medically indicated:
Change the structure& appearance of
healthy vulva or vagina.
ABOUBAKR ELNASHAR
FGM FGCS
1. Practice Condemned Requested
2. Conducted on Girls Adult women
3. Consent Against Mandatory
4. Objective False belief to
control female
sexuality
Improve their
appearance&
sexuality.
ABOUBAKR ELNASHAR
2013:
 In US:
 Labiaplasty was reported to be the 4th most
common cosmetic surgical procedure, rising by
44%.
 Following liposuction, breast augmentation, and rhinoplasty,
 Australia:
 3-fold increase in labiaplasties performed between
2003 and 2013
 UK:
 5-fold increase in these surgeries during the same period.
ABOUBAKR ELNASHAR
CAUSES OF INCREASED DEMAND FOR AES G
1 Perception of ‘normal’ Vs ‘desirable’
‫والمرغوب‬ ‫طبيعي‬ ‫هو‬ ‫لما‬ ‫اﻻدراك‬
ABOUBAKR ELNASHAR
4. Lack of anatomy education throughout life
5. In some countries:
 Decreased cost & shame
 Increased ease of access to Aes G
ABOUBAKR ELNASHAR
 Comparing 2017 to 2016 data.
 11% decrease in surgical procedures
 Increase in laser/nonsurgical interventions
(American Society for Aesthetic Plastic Surgery, 2018)
 This raised the question
 Whether surgical procedures is a passing
trend? (Placik et al, 2019)
INDICATIONS: Why do women seek Aes G?
1. Aesthetic reasons
 To reduce dissatisfaction associated with actual or
perceived abnormality of genital anatomy
2. Functional reasons:
 To reduce
 pain or interference with SI
 discomfort when exercising or wearing tight clothing
 To improve s. function or s. enhancement.
3. Psychological reasons: To address
 embarrassment, poor self-esteem, anxiety
 inhibition in relationships, or to be more 'normal'
ABOUBAKR ELNASHAR
PERFORMED BY
 It is most commonly performed by:
1. Gynaecologists: 50%
2. Plastic surgeons: 30% (Placik et al, 2019)
3. GPs or non-specialist surgeons
(including dermatologists), with additional training in
cosmetic procedures
4. Urologists
ABOUBAKR ELNASHAR
PROCEDURES
I. Vulvoplasty: Augmentation or more frequently,
reduction of the external female genitalia
 Labiaplasty: Augmentation or reduction of the labia
minora, or less commonly the labia majora
 Hymenoplasty or ‘revirgination: Restoration of the
intact hymen
 Clitoral hoodoplasty: Reduction of the clitoral hood
to expose the underlying clitoris
 Vulvar lipoplasty: Removal of fat from mons pubis.
ABOUBAKR ELNASHAR
II. Vaginoplasty: Alteration of the internal female genitalia
 Surgical vaginal tightening
 Perineoplasty: Restoration of perineal length
 Laser Vaginal Rejuvenation: vaginal tightening
using laser therapy
 G-spot augmentation or amplifcation ('G-shot'®)
Autologous fat, collagen, or various filler injections
into a predetermined G-spot'
 Orgasm Shot ('O-Shot’®): Patient’s own blood
products are injected into the clitoris & upper vaginal wall
ABOUBAKR ELNASHAR
 Surgical:
 Non-surgical
1. Energy-Based Procedures: use of
 Lasers or
 Radiofrequency (RF) energy
 US
2. Injection
 Botox
 PRP
 Filler
 Autologs fat
 Collagen ABOUBAKR ELNASHAR
 Wilkie et al, 2018
ABOUBAKR ELNASHAR
ABOUBAKR ELNASHAR
Aesthetic
Genital
Surgery
OPPONENTS
Opponents Of Aes G
1. There is a wide range of normal genitalia:
surgery& rejuvenation procedures unnecessary
(Lloyd et al, 2005)
2. There are numerous marketing claims stating that
these procedures
 enhance sexual satisfaction
 treat both aesthetic& functional issues:
patients request surgery for the wrong
reasons (Braun, 2010)
ABOUBAKR ELNASHAR
3. These procedures are lucrative
patients pay out of cost for these procedures,
raising concerns about direct patient cost& provider
conflict (Lglesia, 2012)
ABOUBAKR ELNASHAR
4. A number of patients seeking Aes G are
 at risk of body dysmorphic disorder
(Recurrent obsessive ideas that a particular aspect of
their appearance is severely faulty)
should be treated, rather than proceeding with
Aes G (Higgins, Wysong, 2018)
ABOUBAKR ELNASHAR
5. The performance of some procedures can be
accepted in some instances
Others:
 No medical justification or biological
acceptability.
 Unethical (Pedro et al, 2018)
ABOUBAKR ELNASHAR
6. Protrusion of the labia minora’
 not a medical problem, but a cultural one.
 Therefore, the solution should be
 Cultural change
 Female -centred strategies that support body-
positivity for women, rather than surgery (Nurka,
2019)
ABOUBAKR ELNASHAR
ABOUBAKR ELNASHAR
Aesthetic
Genital
Surgery
PROPONENTS
Proponents Of Aes G
1. We should maintain
 Patient autonomy for a woman requesting
surgery
 For reasons that she believes important to her,
even if severe anatomic pathology cannot be
exhibited (Cartwright, Cardozo, 2014)
‫الذاتي‬ ‫الحكم‬
ABOUBAKR ELNASHAR
2. One of the most basic human rights is
 right to self-choice & self-governance,
 Free from
 interference by others
 limitations (including inadequate education or
inability to speak for themselves) to making an
autonomous choice (Cain et al, 2013)
‫الذاتي‬ ‫الحكم‬
ABOUBAKR ELNASHAR
3. A patient's desire for
 Symmetry
 Lack of functional restriction
 Improved sexual function& relationships
positive self-image
are reasonable concerns
it is difficult to argue with
what a patient believes as real or perceived
anatomical distortion.
ABOUBAKR ELNASHAR
4. As long as there is
proper preoperative counseling&
patients have realistic expectations about
outcomes,
they should be free to decide for Aes G.
ABOUBAKR ELNASHAR
5. The initial controversies over Aes G have almost
settled down
Evidence suggesting that a number of procedures are
 Safe
 Effective
 Capable of treating to a considerable extent the
conditions associated with life vulvo-vaginal
changes.
 Delivering What Women Want (Magon, Alinsod;
2018)
ABOUBAKR ELNASHAR
ABOUBAKR ELNASHAR
6. Overall patient satisfaction rates: high(Goodman, 2008)
 Complications: 4% to 18% of women (Alter, 2008,
Goodman, 2010)
ETHICAL GUDELINES
 Evidence based
1. RCOG, 2013
2. SOGC, 2013
3. RANZCOG: Royal Australian& New Zealand College of
Obstetricians and Gynaecologists, 2011, 2015
4. FIGO: 2015
5. ACOG: 2007, 2013, 2017
6. ISSVD: International Society for the Study of Vulvovaginal
Disease, 2018
7. ISSVD & ICS, 2019
8. ACOG, 2020
 ALL state that
they cannot clearly support such surgery ethically.
(Goldstein, Jutrzonka, 2016)
ABOUBAKR ELNASHAR
 All (Goldstein, Jutrzonka, 2016)
1.There is a need to exercise caution in providing
Aes G. The message is clear: there is inadequate
evidence to support the beneficial claims of Aes G.
2.The need for informed consent & lack of clear
evidence on which to base such consent.
3.The procedures are not medically indicated& are
not part of the training of gynecologists or plastic
surgeons during residency.
ABOUBAKR ELNASHAR
4. Conflict of interest and the veracity of web-based advertising.
5. Terms commonly used to advertise these procedures
are
 poorly understood
 marketing terms only
 Non-medical terms:
 Vaginal rejuvenation
 Clitoral resurfacing
 G-spot enhancement
ABOUBAKR ELNASHAR
 RCOG Ethics Committee, 2013
1. Counseling
1. Normal variations of vulva
2. Body image distress
3. Risks
4. Lack of reliable evidence of postive effects
2. Written records of physical & mental health reasons for the procedure
3. Advertising should not mislead people on
 what is deemed to be normal or
 what is possible with surgey
4.FGCS should not be undertaken within the NHS
unless it is medically indicated
ABOUBAKR ELNASHAR
 ACOG, 2017
 Minimal adequate long-term studies addressing
satisfaction, safety, and complication rates
 Use of fractional laser is not FDA approved for
gynecologic uses including vulvovaginal
atrophy or rejuvenation.
ABOUBAKR ELNASHAR
ABOUBAKR ELNASHAR
II. FDA 2018:
 Not approved any energy-based device for vag cosmetic
improvement or TT of symptoms associated with the GMS.
 Neither the safety nor effectiveness of these devices for
treatment
 Warns against use of laser-type devices as their use
may result in serious adverse events
 Vaginal burns
 Scarring
 Dyspareunia
 Recurring/chronic pain
III. The International Society for the Study of Vulvovaginal
Disease, 2018
• We strongly recommend against
 G-spot augmentation
 Hymenoplasty
 Vulvar& perianal bleaching/whitening
 Any FGCS with the intention of enhancing sexual
function
{lack of evidence to demonstrate benefit in the literature}.
• Robust evidence to support the use of laser or
radiofrequency to treat vaginal atrophy or “vaginal laxity” is
lacking ABOUBAKR ELNASHAR
ABOUBAKR ELNASHAR
 The International Society for the Study of
Vulvovaginal Disease (ISSVD) and
International Continence Society (ICS) , 2019
 Based on the available scientific evidence, with no
supporting long term follow-up data:
 use of LASER should, at present, not be
recommended for TT of
 Vaginal atrophy
 Vulvodynia, or
 Lichen sclerosus.
 The data for the role of LASER for
 Stress urinary incontinence&
 Vaginal laxity are inadequate to draw any
conclusions or safe practice
recommendations.
ABOUBAKR ELNASHAR
 ACOG 2020
 Lack of
 Published studies
 Standardized nomenclature
 Outcomes: risks & benefits.
 Counseling:
 Effectiveness: lack of high-quality data that support
 Potential complications: pain, bleeding, infection,
scarring, adhesions, altered sensation, dyspareunia, and
need for reoperation.
ABOUBAKR ELNASHAR
 Gynecologists should have sufficient training to recognize
women with
 Sexual dysfunction
 Psychiatric conditions:
 depression, anxiety
 body dysmorphic disorder.
 referral for evaluation before surgery.
 Gynecologist: inform patients about outcomes
 Substantial risk
 Safety & effectiveness have not been established.
ABOUBAKR ELNASHAR
 NICE 2021.
 The evidence on TV laser therapy for SUI or
urogenital atrophy does not show any short-
term safety concerns.
 Evidence on long-term safety & efficacy is
inadequate in quality and quantity.
 Therefore, this procedure should only be used
in the context of research.
You can get this lecture and 480 lectures from:
1.My scientific page on Face book: Aboubakr
Elnashar Lectures.
https://www.facebook.com/groups/2277448840913
51/
2.Slide share web site
3.elnashar53@hotmail.com
4.My clinic: Elthwara St. Mansura

More Related Content

What's hot

PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
Lifecare Centre
 
Vaginoplasty. An update and future concern
Vaginoplasty. An update and future concernVaginoplasty. An update and future concern
Vaginoplasty. An update and future concern
Mahmoud Abdel-Aleem
 
Fibroid and infertility
Fibroid and infertilityFibroid and infertility
Fibroid and infertility
Aboubakr Elnashar
 
Diagnosis and classification of tubal factor infertility
Diagnosis and classification of tubal factor infertilityDiagnosis and classification of tubal factor infertility
Diagnosis and classification of tubal factor infertilitySanjay Makwana
 
Female infertility
Female infertility Female infertility
Female infertility
Aboubakr Elnashar
 
Mini Review of Aesthetic Gynecology
Mini Review of Aesthetic GynecologyMini Review of Aesthetic Gynecology
Mini Review of Aesthetic Gynecology
Maheen Fatima
 
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Lifecare Centre
 
Tests for ovarian reserve
Tests for ovarian reserveTests for ovarian reserve
Tests for ovarian reserve
NARENDRA MALHOTRA
 
Emerging treatment of endometriosis
Emerging treatment of endometriosisEmerging treatment of endometriosis
Emerging treatment of endometriosis
Aboubakr Elnashar
 
Fertility Enhancing Laparoscopic Surgeries Panel Discussion
Fertility Enhancing Laparoscopic Surgeries Panel DiscussionFertility Enhancing Laparoscopic Surgeries Panel Discussion
Fertility Enhancing Laparoscopic Surgeries Panel Discussion
Rajesh Gajbhiye
 
Fertility Preserving Hysteroscopic Surgery
Fertility Preserving Hysteroscopic SurgeryFertility Preserving Hysteroscopic Surgery
Fertility Preserving Hysteroscopic Surgery
Sujoy Dasgupta
 
ADOLESCENT ENDOMETRIOSIS
ADOLESCENT ENDOMETRIOSISADOLESCENT ENDOMETRIOSIS
ADOLESCENT ENDOMETRIOSIS
Aboubakr Elnashar
 
CS scar niche.
CS scar niche.CS scar niche.
CS scar niche.
magdy abdel
 
Thin Endometrium
Thin EndometriumThin Endometrium
Thin Endometrium
Sujoy Dasgupta
 
Difficult Cases in IUI
Difficult Cases in IUIDifficult Cases in IUI
Difficult Cases in IUI
Sujoy Dasgupta
 
Adenomyosis associated infertility: Review of systematic reviews
Adenomyosis associated infertility: Review of systematic reviewsAdenomyosis associated infertility: Review of systematic reviews
Adenomyosis associated infertility: Review of systematic reviews
Aboubakr Elnashar
 
Laproscopy in gynecology oncology
Laproscopy in gynecology oncologyLaproscopy in gynecology oncology
Laproscopy in gynecology oncologyTariq Mohammed
 
Vaginoplasty
Vaginoplasty Vaginoplasty
Endometriosis
EndometriosisEndometriosis
Endometriosis
Aboubakr Elnashar
 
DIENOGEST BY DR SHASHWAT JANI
DIENOGEST BY DR SHASHWAT JANIDIENOGEST BY DR SHASHWAT JANI
DIENOGEST BY DR SHASHWAT JANI
DR SHASHWAT JANI
 

What's hot (20)

PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
 
Vaginoplasty. An update and future concern
Vaginoplasty. An update and future concernVaginoplasty. An update and future concern
Vaginoplasty. An update and future concern
 
Fibroid and infertility
Fibroid and infertilityFibroid and infertility
Fibroid and infertility
 
Diagnosis and classification of tubal factor infertility
Diagnosis and classification of tubal factor infertilityDiagnosis and classification of tubal factor infertility
Diagnosis and classification of tubal factor infertility
 
Female infertility
Female infertility Female infertility
Female infertility
 
Mini Review of Aesthetic Gynecology
Mini Review of Aesthetic GynecologyMini Review of Aesthetic Gynecology
Mini Review of Aesthetic Gynecology
 
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
 
Tests for ovarian reserve
Tests for ovarian reserveTests for ovarian reserve
Tests for ovarian reserve
 
Emerging treatment of endometriosis
Emerging treatment of endometriosisEmerging treatment of endometriosis
Emerging treatment of endometriosis
 
Fertility Enhancing Laparoscopic Surgeries Panel Discussion
Fertility Enhancing Laparoscopic Surgeries Panel DiscussionFertility Enhancing Laparoscopic Surgeries Panel Discussion
Fertility Enhancing Laparoscopic Surgeries Panel Discussion
 
Fertility Preserving Hysteroscopic Surgery
Fertility Preserving Hysteroscopic SurgeryFertility Preserving Hysteroscopic Surgery
Fertility Preserving Hysteroscopic Surgery
 
ADOLESCENT ENDOMETRIOSIS
ADOLESCENT ENDOMETRIOSISADOLESCENT ENDOMETRIOSIS
ADOLESCENT ENDOMETRIOSIS
 
CS scar niche.
CS scar niche.CS scar niche.
CS scar niche.
 
Thin Endometrium
Thin EndometriumThin Endometrium
Thin Endometrium
 
Difficult Cases in IUI
Difficult Cases in IUIDifficult Cases in IUI
Difficult Cases in IUI
 
Adenomyosis associated infertility: Review of systematic reviews
Adenomyosis associated infertility: Review of systematic reviewsAdenomyosis associated infertility: Review of systematic reviews
Adenomyosis associated infertility: Review of systematic reviews
 
Laproscopy in gynecology oncology
Laproscopy in gynecology oncologyLaproscopy in gynecology oncology
Laproscopy in gynecology oncology
 
Vaginoplasty
Vaginoplasty Vaginoplasty
Vaginoplasty
 
Endometriosis
EndometriosisEndometriosis
Endometriosis
 
DIENOGEST BY DR SHASHWAT JANI
DIENOGEST BY DR SHASHWAT JANIDIENOGEST BY DR SHASHWAT JANI
DIENOGEST BY DR SHASHWAT JANI
 

Similar to Aesthetic gynecology controversy

Laser Vaginal Rejuvenation_Crimson publishers
Laser Vaginal Rejuvenation_Crimson publishersLaser Vaginal Rejuvenation_Crimson publishers
Laser Vaginal Rejuvenation_Crimson publishers
CrimsonPublishers-PRM
 
Surgical treatment of infertility: pre and post - Dr. Abayomi Ajayi
Surgical treatment of infertility: pre and post - Dr. Abayomi AjayiSurgical treatment of infertility: pre and post - Dr. Abayomi Ajayi
Surgical treatment of infertility: pre and post - Dr. Abayomi Ajayi
abayomi ajayi
 
Fertility Management: Synergy between Endoscopists and Fertility Specialists
Fertility Management: Synergy between Endoscopists and Fertility SpecialistsFertility Management: Synergy between Endoscopists and Fertility Specialists
Fertility Management: Synergy between Endoscopists and Fertility Specialists
Sujoy Dasgupta
 
Infertility Hysteroscopy
Infertility HysteroscopyInfertility Hysteroscopy
Infertility Hysteroscopyguest9dc181
 
Infertility Hysteroscopy
Infertility HysteroscopyInfertility Hysteroscopy
Infertility Hysteroscopyguest9dc181
 
Hysteroscopy in management of AUB in women with intact hymen by Associate Pro...
Hysteroscopy in management of AUB in women with intact hymen by Associate Pro...Hysteroscopy in management of AUB in women with intact hymen by Associate Pro...
Hysteroscopy in management of AUB in women with intact hymen by Associate Pro...
Dr. Aisha M Elbareg
 
Infertility up to date1
Infertility up to date1Infertility up to date1
Infertility up to date1
RihabAbbasAli
 
Impact of female genital cutting on maternal and reproductive health
Impact of female genital cutting on maternal and reproductive health Impact of female genital cutting on maternal and reproductive health
Impact of female genital cutting on maternal and reproductive health
Aboubakr Elnashar
 
Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??
NARENDRA MALHOTRA
 
Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What D...
Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What D...Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What D...
Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What D...
PVI, PeerView Institute for Medical Education
 
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
Aboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
Aboubakr Elnashar
 
The Newer Concepts for Reduced Surgery to preserve fertility in Endometrios...
The Newer Concepts  forReduced Surgery to preserve fertility in Endometrios...The Newer Concepts  forReduced Surgery to preserve fertility in Endometrios...
The Newer Concepts for Reduced Surgery to preserve fertility in Endometrios...
Lifecare Centre
 
Endometriosis and INFERTILITY an update Dr. Sharda Jain / Dr. Jyoti Agarwal, ...
Endometriosis and INFERTILITY an update Dr. Sharda Jain / Dr. Jyoti Agarwal, ...Endometriosis and INFERTILITY an update Dr. Sharda Jain / Dr. Jyoti Agarwal, ...
Endometriosis and INFERTILITY an update Dr. Sharda Jain / Dr. Jyoti Agarwal, ...Lifecare Centre
 
SAVE THE UTERUS
SAVE THE UTERUSSAVE THE UTERUS
Endometrial Hyperplasia & Cancer Uterus Explain by Dr. Laxmi Shrikhande
Endometrial Hyperplasia & Cancer Uterus Explain by Dr. Laxmi ShrikhandeEndometrial Hyperplasia & Cancer Uterus Explain by Dr. Laxmi Shrikhande
Endometrial Hyperplasia & Cancer Uterus Explain by Dr. Laxmi Shrikhande
Dr.Laxmi Agrawal Shrikhande
 
Hysteroscopic endometrial resection in the management of abnormal uterine ble...
Hysteroscopic endometrial resection in the management of abnormal uterine ble...Hysteroscopic endometrial resection in the management of abnormal uterine ble...
Hysteroscopic endometrial resection in the management of abnormal uterine ble...
Dr. Aisha M Elbareg
 
Evidence based individual decision making
Evidence based individual decision makingEvidence based individual decision making
Evidence based individual decision making
Mohammed Abdalla
 
Overview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy LossOverview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy Loss
Dr.Laxmi Agrawal Shrikhande
 

Similar to Aesthetic gynecology controversy (20)

Laser Vaginal Rejuvenation_Crimson publishers
Laser Vaginal Rejuvenation_Crimson publishersLaser Vaginal Rejuvenation_Crimson publishers
Laser Vaginal Rejuvenation_Crimson publishers
 
Surgical treatment of infertility: pre and post - Dr. Abayomi Ajayi
Surgical treatment of infertility: pre and post - Dr. Abayomi AjayiSurgical treatment of infertility: pre and post - Dr. Abayomi Ajayi
Surgical treatment of infertility: pre and post - Dr. Abayomi Ajayi
 
Fertility Management: Synergy between Endoscopists and Fertility Specialists
Fertility Management: Synergy between Endoscopists and Fertility SpecialistsFertility Management: Synergy between Endoscopists and Fertility Specialists
Fertility Management: Synergy between Endoscopists and Fertility Specialists
 
Infertility Hysteroscopy
Infertility HysteroscopyInfertility Hysteroscopy
Infertility Hysteroscopy
 
Infertility Hysteroscopy
Infertility HysteroscopyInfertility Hysteroscopy
Infertility Hysteroscopy
 
Hysteroscopy in management of AUB in women with intact hymen by Associate Pro...
Hysteroscopy in management of AUB in women with intact hymen by Associate Pro...Hysteroscopy in management of AUB in women with intact hymen by Associate Pro...
Hysteroscopy in management of AUB in women with intact hymen by Associate Pro...
 
Infertility up to date1
Infertility up to date1Infertility up to date1
Infertility up to date1
 
Impact of female genital cutting on maternal and reproductive health
Impact of female genital cutting on maternal and reproductive health Impact of female genital cutting on maternal and reproductive health
Impact of female genital cutting on maternal and reproductive health
 
Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??Hysteroscopy pre IVF is it neccessary ??
Hysteroscopy pre IVF is it neccessary ??
 
Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What D...
Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What D...Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What D...
Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What D...
 
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
The Newer Concepts for Reduced Surgery to preserve fertility in Endometrios...
The Newer Concepts  forReduced Surgery to preserve fertility in Endometrios...The Newer Concepts  forReduced Surgery to preserve fertility in Endometrios...
The Newer Concepts for Reduced Surgery to preserve fertility in Endometrios...
 
Endometriosis and INFERTILITY an update Dr. Sharda Jain / Dr. Jyoti Agarwal, ...
Endometriosis and INFERTILITY an update Dr. Sharda Jain / Dr. Jyoti Agarwal, ...Endometriosis and INFERTILITY an update Dr. Sharda Jain / Dr. Jyoti Agarwal, ...
Endometriosis and INFERTILITY an update Dr. Sharda Jain / Dr. Jyoti Agarwal, ...
 
SAVE THE UTERUS
SAVE THE UTERUSSAVE THE UTERUS
SAVE THE UTERUS
 
Journal of-sexual-medicine-laser-vaginal-rejuvenation-dr-jason
Journal of-sexual-medicine-laser-vaginal-rejuvenation-dr-jasonJournal of-sexual-medicine-laser-vaginal-rejuvenation-dr-jason
Journal of-sexual-medicine-laser-vaginal-rejuvenation-dr-jason
 
Endometrial Hyperplasia & Cancer Uterus Explain by Dr. Laxmi Shrikhande
Endometrial Hyperplasia & Cancer Uterus Explain by Dr. Laxmi ShrikhandeEndometrial Hyperplasia & Cancer Uterus Explain by Dr. Laxmi Shrikhande
Endometrial Hyperplasia & Cancer Uterus Explain by Dr. Laxmi Shrikhande
 
Hysteroscopic endometrial resection in the management of abnormal uterine ble...
Hysteroscopic endometrial resection in the management of abnormal uterine ble...Hysteroscopic endometrial resection in the management of abnormal uterine ble...
Hysteroscopic endometrial resection in the management of abnormal uterine ble...
 
Evidence based individual decision making
Evidence based individual decision makingEvidence based individual decision making
Evidence based individual decision making
 
Overview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy LossOverview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy Loss
 

More from Aboubakr Elnashar

hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
Aboubakr Elnashar
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
Aboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
Aboubakr Elnashar
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
Aboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
Aboubakr Elnashar
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
Aboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
Aboubakr Elnashar
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
Aboubakr Elnashar
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
Aboubakr Elnashar
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
Aboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
Aboubakr Elnashar
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
Aboubakr Elnashar
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
Aboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
Aboubakr Elnashar
 
Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1
Aboubakr Elnashar
 
update on PCOS
update on PCOSupdate on PCOS
update on PCOS
Aboubakr Elnashar
 
PREECLAMPSIA‐ECLAMPSIA SPECTRUM
PREECLAMPSIA‐ECLAMPSIA SPECTRUMPREECLAMPSIA‐ECLAMPSIA SPECTRUM
PREECLAMPSIA‐ECLAMPSIA SPECTRUM
Aboubakr Elnashar
 
Ovarian cysts and infertility
Ovarian cysts and infertilityOvarian cysts and infertility
Ovarian cysts and infertility
Aboubakr Elnashar
 

More from Aboubakr Elnashar (20)

hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 
Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1
 
update on PCOS
update on PCOSupdate on PCOS
update on PCOS
 
PREECLAMPSIA‐ECLAMPSIA SPECTRUM
PREECLAMPSIA‐ECLAMPSIA SPECTRUMPREECLAMPSIA‐ECLAMPSIA SPECTRUM
PREECLAMPSIA‐ECLAMPSIA SPECTRUM
 
Ovarian cysts and infertility
Ovarian cysts and infertilityOvarian cysts and infertility
Ovarian cysts and infertility
 

Recently uploaded

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 

Recently uploaded (20)

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 

Aesthetic gynecology controversy

  • 1. CONTROVERSIES IN AESTHETIC GYNECOLOGY Prof. Aboubakr Elnashar Benha university Hospital, Egypt ABOUBAKR ELNASHAR
  • 2. ABOUBAKR ELNASHAR CONTENTS  INTRODUCTION 1. DEFINITION 2. STATISTICS 3. CAUSES OF INCREASED DEMAND FOR FGCS 4. INDICATIONS 5. PROCEDURES 6. OUTCOMES  CONTROVERSY 1. OPPONENTS 2. PROPONENTS 3. ETHICAL GUIDELINES
  • 3.  Aesthetic Gynecology: Aes G Alteration of anatomy vaginal or labial: for Aesthetic reasons (artistic& visual) or Treatment of normal changes that occur throughout the life span. Cosmetic procedures Non medically indicated: Change the structure& appearance of healthy vulva or vagina. ABOUBAKR ELNASHAR
  • 4. FGM FGCS 1. Practice Condemned Requested 2. Conducted on Girls Adult women 3. Consent Against Mandatory 4. Objective False belief to control female sexuality Improve their appearance& sexuality. ABOUBAKR ELNASHAR
  • 5. 2013:  In US:  Labiaplasty was reported to be the 4th most common cosmetic surgical procedure, rising by 44%.  Following liposuction, breast augmentation, and rhinoplasty,  Australia:  3-fold increase in labiaplasties performed between 2003 and 2013  UK:  5-fold increase in these surgeries during the same period. ABOUBAKR ELNASHAR
  • 6. CAUSES OF INCREASED DEMAND FOR AES G 1 Perception of ‘normal’ Vs ‘desirable’ ‫والمرغوب‬ ‫طبيعي‬ ‫هو‬ ‫لما‬ ‫اﻻدراك‬ ABOUBAKR ELNASHAR
  • 7. 4. Lack of anatomy education throughout life 5. In some countries:  Decreased cost & shame  Increased ease of access to Aes G ABOUBAKR ELNASHAR
  • 8.  Comparing 2017 to 2016 data.  11% decrease in surgical procedures  Increase in laser/nonsurgical interventions (American Society for Aesthetic Plastic Surgery, 2018)  This raised the question  Whether surgical procedures is a passing trend? (Placik et al, 2019)
  • 9. INDICATIONS: Why do women seek Aes G? 1. Aesthetic reasons  To reduce dissatisfaction associated with actual or perceived abnormality of genital anatomy 2. Functional reasons:  To reduce  pain or interference with SI  discomfort when exercising or wearing tight clothing  To improve s. function or s. enhancement. 3. Psychological reasons: To address  embarrassment, poor self-esteem, anxiety  inhibition in relationships, or to be more 'normal' ABOUBAKR ELNASHAR
  • 10. PERFORMED BY  It is most commonly performed by: 1. Gynaecologists: 50% 2. Plastic surgeons: 30% (Placik et al, 2019) 3. GPs or non-specialist surgeons (including dermatologists), with additional training in cosmetic procedures 4. Urologists ABOUBAKR ELNASHAR
  • 11. PROCEDURES I. Vulvoplasty: Augmentation or more frequently, reduction of the external female genitalia  Labiaplasty: Augmentation or reduction of the labia minora, or less commonly the labia majora  Hymenoplasty or ‘revirgination: Restoration of the intact hymen  Clitoral hoodoplasty: Reduction of the clitoral hood to expose the underlying clitoris  Vulvar lipoplasty: Removal of fat from mons pubis. ABOUBAKR ELNASHAR
  • 12. II. Vaginoplasty: Alteration of the internal female genitalia  Surgical vaginal tightening  Perineoplasty: Restoration of perineal length  Laser Vaginal Rejuvenation: vaginal tightening using laser therapy  G-spot augmentation or amplifcation ('G-shot'®) Autologous fat, collagen, or various filler injections into a predetermined G-spot'  Orgasm Shot ('O-Shot’®): Patient’s own blood products are injected into the clitoris & upper vaginal wall ABOUBAKR ELNASHAR
  • 13.  Surgical:  Non-surgical 1. Energy-Based Procedures: use of  Lasers or  Radiofrequency (RF) energy  US 2. Injection  Botox  PRP  Filler  Autologs fat  Collagen ABOUBAKR ELNASHAR
  • 14.  Wilkie et al, 2018 ABOUBAKR ELNASHAR
  • 16. Opponents Of Aes G 1. There is a wide range of normal genitalia: surgery& rejuvenation procedures unnecessary (Lloyd et al, 2005) 2. There are numerous marketing claims stating that these procedures  enhance sexual satisfaction  treat both aesthetic& functional issues: patients request surgery for the wrong reasons (Braun, 2010) ABOUBAKR ELNASHAR
  • 17. 3. These procedures are lucrative patients pay out of cost for these procedures, raising concerns about direct patient cost& provider conflict (Lglesia, 2012) ABOUBAKR ELNASHAR
  • 18. 4. A number of patients seeking Aes G are  at risk of body dysmorphic disorder (Recurrent obsessive ideas that a particular aspect of their appearance is severely faulty) should be treated, rather than proceeding with Aes G (Higgins, Wysong, 2018) ABOUBAKR ELNASHAR
  • 19. 5. The performance of some procedures can be accepted in some instances Others:  No medical justification or biological acceptability.  Unethical (Pedro et al, 2018) ABOUBAKR ELNASHAR
  • 20. 6. Protrusion of the labia minora’  not a medical problem, but a cultural one.  Therefore, the solution should be  Cultural change  Female -centred strategies that support body- positivity for women, rather than surgery (Nurka, 2019) ABOUBAKR ELNASHAR
  • 22. Proponents Of Aes G 1. We should maintain  Patient autonomy for a woman requesting surgery  For reasons that she believes important to her, even if severe anatomic pathology cannot be exhibited (Cartwright, Cardozo, 2014) ‫الذاتي‬ ‫الحكم‬ ABOUBAKR ELNASHAR
  • 23. 2. One of the most basic human rights is  right to self-choice & self-governance,  Free from  interference by others  limitations (including inadequate education or inability to speak for themselves) to making an autonomous choice (Cain et al, 2013) ‫الذاتي‬ ‫الحكم‬ ABOUBAKR ELNASHAR
  • 24. 3. A patient's desire for  Symmetry  Lack of functional restriction  Improved sexual function& relationships positive self-image are reasonable concerns it is difficult to argue with what a patient believes as real or perceived anatomical distortion. ABOUBAKR ELNASHAR
  • 25. 4. As long as there is proper preoperative counseling& patients have realistic expectations about outcomes, they should be free to decide for Aes G. ABOUBAKR ELNASHAR
  • 26. 5. The initial controversies over Aes G have almost settled down Evidence suggesting that a number of procedures are  Safe  Effective  Capable of treating to a considerable extent the conditions associated with life vulvo-vaginal changes.  Delivering What Women Want (Magon, Alinsod; 2018) ABOUBAKR ELNASHAR
  • 27. ABOUBAKR ELNASHAR 6. Overall patient satisfaction rates: high(Goodman, 2008)  Complications: 4% to 18% of women (Alter, 2008, Goodman, 2010)
  • 28. ETHICAL GUDELINES  Evidence based 1. RCOG, 2013 2. SOGC, 2013 3. RANZCOG: Royal Australian& New Zealand College of Obstetricians and Gynaecologists, 2011, 2015 4. FIGO: 2015 5. ACOG: 2007, 2013, 2017 6. ISSVD: International Society for the Study of Vulvovaginal Disease, 2018 7. ISSVD & ICS, 2019 8. ACOG, 2020  ALL state that they cannot clearly support such surgery ethically. (Goldstein, Jutrzonka, 2016) ABOUBAKR ELNASHAR
  • 29.  All (Goldstein, Jutrzonka, 2016) 1.There is a need to exercise caution in providing Aes G. The message is clear: there is inadequate evidence to support the beneficial claims of Aes G. 2.The need for informed consent & lack of clear evidence on which to base such consent. 3.The procedures are not medically indicated& are not part of the training of gynecologists or plastic surgeons during residency. ABOUBAKR ELNASHAR
  • 30. 4. Conflict of interest and the veracity of web-based advertising. 5. Terms commonly used to advertise these procedures are  poorly understood  marketing terms only  Non-medical terms:  Vaginal rejuvenation  Clitoral resurfacing  G-spot enhancement ABOUBAKR ELNASHAR
  • 31.  RCOG Ethics Committee, 2013 1. Counseling 1. Normal variations of vulva 2. Body image distress 3. Risks 4. Lack of reliable evidence of postive effects 2. Written records of physical & mental health reasons for the procedure 3. Advertising should not mislead people on  what is deemed to be normal or  what is possible with surgey 4.FGCS should not be undertaken within the NHS unless it is medically indicated ABOUBAKR ELNASHAR
  • 32.  ACOG, 2017  Minimal adequate long-term studies addressing satisfaction, safety, and complication rates  Use of fractional laser is not FDA approved for gynecologic uses including vulvovaginal atrophy or rejuvenation. ABOUBAKR ELNASHAR
  • 33. ABOUBAKR ELNASHAR II. FDA 2018:  Not approved any energy-based device for vag cosmetic improvement or TT of symptoms associated with the GMS.  Neither the safety nor effectiveness of these devices for treatment  Warns against use of laser-type devices as their use may result in serious adverse events  Vaginal burns  Scarring  Dyspareunia  Recurring/chronic pain
  • 34. III. The International Society for the Study of Vulvovaginal Disease, 2018 • We strongly recommend against  G-spot augmentation  Hymenoplasty  Vulvar& perianal bleaching/whitening  Any FGCS with the intention of enhancing sexual function {lack of evidence to demonstrate benefit in the literature}. • Robust evidence to support the use of laser or radiofrequency to treat vaginal atrophy or “vaginal laxity” is lacking ABOUBAKR ELNASHAR
  • 35. ABOUBAKR ELNASHAR  The International Society for the Study of Vulvovaginal Disease (ISSVD) and International Continence Society (ICS) , 2019  Based on the available scientific evidence, with no supporting long term follow-up data:  use of LASER should, at present, not be recommended for TT of  Vaginal atrophy  Vulvodynia, or  Lichen sclerosus.
  • 36.  The data for the role of LASER for  Stress urinary incontinence&  Vaginal laxity are inadequate to draw any conclusions or safe practice recommendations.
  • 37. ABOUBAKR ELNASHAR  ACOG 2020  Lack of  Published studies  Standardized nomenclature  Outcomes: risks & benefits.  Counseling:  Effectiveness: lack of high-quality data that support  Potential complications: pain, bleeding, infection, scarring, adhesions, altered sensation, dyspareunia, and need for reoperation.
  • 38. ABOUBAKR ELNASHAR  Gynecologists should have sufficient training to recognize women with  Sexual dysfunction  Psychiatric conditions:  depression, anxiety  body dysmorphic disorder.  referral for evaluation before surgery.  Gynecologist: inform patients about outcomes  Substantial risk  Safety & effectiveness have not been established.
  • 39. ABOUBAKR ELNASHAR  NICE 2021.  The evidence on TV laser therapy for SUI or urogenital atrophy does not show any short- term safety concerns.  Evidence on long-term safety & efficacy is inadequate in quality and quantity.  Therefore, this procedure should only be used in the context of research.
  • 40. You can get this lecture and 480 lectures from: 1.My scientific page on Face book: Aboubakr Elnashar Lectures. https://www.facebook.com/groups/2277448840913 51/ 2.Slide share web site 3.elnashar53@hotmail.com 4.My clinic: Elthwara St. Mansura